BENOQUIN 40 Cream
Product Description
BENOQUIN 40 Cream is a topical depigmenting formulation containing Monobenzone 40% w/w, primarily used for permanent depigmentation of remaining normal skin in patients with extensive vitiligo (leukoderma). It works by reducing melanin production in the skin, helping achieve a more uniform skin tone where repigmentation therapies are no longer effective.
The cream is formulated for external use only and should be applied strictly under the guidance of a qualified medical professional. BENOQUIN 40 is well known in dermatological practice for cases where cosmetic uniformity is clinically indicated.
Key Features
Contains Monobenzone 40% w/w
Used in advanced or extensive vitiligo management
Helps in permanent depigmentation of unaffected skin
Smooth, easy-to-apply cream base
Dermatologist-prescribed formulation
Mechanism of Action
Monobenzone causes irreversible destruction of melanocytes, leading to long-term depigmentation. This action helps balance skin tone in patients with widespread vitiligo.
Indications
Extensive vitiligo (leukoderma)
Cases where repigmentation therapy is unsuccessful
Cosmetic skin tone uniformity under medical supervision
Usage & Precautions
For external use only
Apply as directed by a healthcare professional
Avoid contact with eyes, mouth, and broken skin
Sun protection is strongly recommended during use
Not intended for cosmetic fairness or general skin lightening
Storage
Store below 25°C
Protect from light and moisture
Keep out of reach of children
Packaging
Tube packing (commonly 20 g / 30 g, depending on manufacturer)
Secure, tamper-evident packaging for safe distribution
